Fox BusinessNovo Nordisk's Wegovy reduces risk of serious heart problems by 20%, study showsNov 13, 2023Daniella Alessandra GenoveseBy Daniella Alessandra Genovesemore_vert
Yale School of MedicineAnti-obesity Medication Semaglutide (Wegovy®) Could Benefit Millions of Americans With Obesity and Cardiovascular ...Nov 15, 2023Isabella BackmanBy Isabella Backmanmore_vert
ReutersWegovy's heart benefits due to more than weight loss, Novo saysNov 13, 2023Patrick WingroveBy Patrick Wingrovemore_vert
Cleveland Clinic NewsroomInternational Clinical Trial Finds that Semaglutide Reduced Cardiovascular Events by 20% in Adults with Overweight or ...Nov 11, 2023more_vert
Financial TimesNovo Nordisk's obesity drug cuts risk of death by 18%, trial data showsNov 11, 2023Hannah KuchlerBy Hannah Kuchlermore_vert
CBS NewsWeight loss drug Wegovy cut risk of serious heart problems by 20%, study findsNov 13, 2023more_vert
ReutersNovo Nordisk shares rise as Wegovy shows heart benefits beyond weight lossNov 13, 2023Maggie FickBy Maggie Fickmore_vert
New ScientistWeight-loss drug Wegovy can avert heart attacks - will this widen use?Nov 11, 2023Clare WilsonBy Clare Wilsonmore_vert
WIREDWegovy Slashes the Risk of Heart Attack and Stroke in a Landmark TrialNov 11, 2023Emily MullinBy Emily Mullinmore_vert
MedscapeSemaglutide 'A New Pathway' to CVD Risk Reduction: SELECTNov 11, 2023Sue HughesBy Sue Hughesmore_vert
TIMEWeight Loss Drug Wegovy Can Also Reduce Risk of Heart EventsNov 11, 2023Alice ParkBy Alice Parkmore_vert
The Associated PressObesity drug Wegovy cut risk of serious heart problems by 20%, study findsNov 11, 2023JoNel AlecciaBy JoNel Alecciamore_vert
BloombergWegovy Weight Loss Drug May Also Treat Heart Disease, Study ShowsNov 11, 2023Naomi Kresge & Madison MullerBy Naomi Kresge & Madison Mullermore_vert
New York Post Wegovy cuts risk of serious heart problems by 20%: landmark studyNov 12, 2023Taylor KnightBy Taylor Knightmore_vert
STATWegovy cuts risk of heart attacks in milestone cardiovascular trialNov 11, 2023Elaine ChenBy Elaine Chenmore_vert
Scientific AmericanWeight-Loss Drug Wegovy Slashes Risk of Death in Some People with Heart DiseaseNov 17, 2023Sara ReardonBy Sara Reardonmore_vert
Ars TechnicaObesity drug Wegovy reduces cardiovascular risks for those at high riskNov 13, 2023Beth MoleBy Beth Molemore_vert
NBC NewsWhy weight-loss drug Wegovy shows promise for heart diseaseNov 11, 2023Berkeley Lovelace & Berkeley Lovelace Jr.By Berkeley Lovelace & Berkeley Lovelace Jr.more_vert
CNNTrial confirms heart benefits of Wegovy, but is weight loss responsible – or something else?Nov 11, 2023Meg TirrellBy Meg Tirrellmore_vert
CNBCNovo Nordisk's weight loss drug Wegovy slashes risk of serious heart eventsNov 11, 2023Angelica PeeblesBy Angelica Peeblesmore_vert
CBS NewsWegovy weight-loss drug reduced risk of serious heart problems by 20%, study findsNov 13, 2023more_vert
The New York TimesWeight Loss Drug Wegovy Can Cut Heart Attack Risk for Some, Study ShowsNov 11, 2023Dani BlumBy Dani Blummore_vert